What to Expect From Procter & Gamble Earnings

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

The Procter & Gamble Co. (NYSE: PG) will report its second-quarter earnings Tuesday before the markets open. Thomson Reuters has consensus estimates of $1.13 in earnings per share and $20.62 billion in revenue. The second quarter from the previous year had $1.15 in earnings per share and $22.28 billion in revenue.

Looking ahead to 2015, what investors have to consider is that P&G is in a state of change. It is selling or willing to dispose of a large number of brands. We opined that Berkshire Hathaway Inc. (NYSE: BRK-A) may be stealing the Duracell brand in that unit disposition process. P&G also arranged for the sale of most of its pet foods operations in 2014.

At the end of 2014, a boutique firm named BTIG issued a downgrade on P&G shares, to Neutral from Buy. Another key issue has been present since last summer, and that is that earnings have little or no growth. Another question is whether brand names just come with too much premium over less recognized brands.

P&G is a stock that most investors flock to during times of uncertainty. It just so happens that consumers still use things like deodorant, toilet paper, diapers, razors, soap, shampoo and a whole host of other consumer products whether or not times are hard. 24/7 Wall St. has included more on the company’s outlook in our Bullish and Bearish Case in 2015.

Just a week before the company will release its earnings, the firm B. Riley reiterated a Neutral rating for P&G and lowered its price target to $87.00 from $91.00.

The 50-day moving average is currently at $89.30. Shares have been testing the 50-day moving average since the beginning of the New Year. The 200-day moving average is immaterial and reads at $82.96.

Shares of P&G were down 1% at $89.25 in the last two hours of trading. The stock has a consensus analyst price target of $92.89 and a 52-week trading range of $75.26 to $93.89. It has a market cap of $242 billion.

One caveat has to be identified ahead of earnings, and that is that there is a lot of change in the process of coming about. P&G has many brands on the block, and that means that analysts could have a very difficult time getting their ‘NewCo’ estimates right.

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618